ID   HMy2.DRN
AC   CVCL_F826
DR   Wikidata; Q54889983
RX   PubMed=2212658;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F825 ! HMy2.A3m
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
RX   PubMed=2212658; DOI=10.4049/jimmunol.145.8.2730;
RA   Koppelman B., Cresswell P.;
RT   "Rapid nonlysosomal degradation of assembled HLA class II
RT   glycoproteins incorporating a mutant DR alpha-chain.";
RL   J. Immunol. 145:2730-2736(1990).
//